切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - LPA - RET - Urokinases - Glucocorticoid Receptors

12件产品中的 1-10

页面
每页
清除全部
  1. ONO-7300243
    B7818 ONO-7300243
    Target: LPA
    Summary: LPA1拮抗剂
      ≥46.1 mg/mL
      insoluble in H2O
  2. Methylprednisolone Sodium Succinate
    B4953 Methylprednisolone Sodium Succinate
    中文名: 甲泼尼龙琥珀酸钠
    Target: Glucocorticoid Receptors
    Summary: 糖皮质激素
      ≥49.7 mg/mL
      ≥2.94 mg/mL
  3. Amiloride HCl dihydrate
    B2268 Amiloride HCl dihydrate
    中文名: 盐酸阿米洛利二水合物
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Urokinases
    Summary: 有效上皮钠通道(ENaC)阻断剂
      ≥14.05 mg/mL
      insoluble in H2O
  4. Fluticasone propionate
    B2096 Fluticasone propionate
    中文名: 丙酸氟替卡松
    Target: Glucocorticoid Receptors
    Summary: 高亲和力,选择性糖皮质激素受体激动剂
      ≥18.5 mg/mL
      insoluble in H2O
  5. Dexamethasone acetate
    B1926 Dexamethasone acetate
    中文名: 醋酸地塞米松
    Target: Glucocorticoid Receptors|interleukin receptor
    Summary: IL受体调节剂
      ≥13.35 mg/mL
      insoluble in H2O
  6. Mifepristone
    B1511 Mifepristone
     3 Citation
    中文名: 美服培酮
    Target: Progesterone Receptors|Glucocorticoid Receptors
    Summary: 孕激素受体拮抗剂
      ≥21.48 mg/mL
      insoluble in H2O
  7. Lenvatinib (E7080)
    A2174 Lenvatinib (E7080)
    中文名: 乐伐替尼,仑伐替尼
    Target: VEGFR|PDGFR|RET
    Summary: VEGFR抑制剂
      ≥21.35 mg/mL
      insoluble in H2O
  8. Regorafenib
    A8236 Regorafenib
     4 Citation
    中文名: 瑞戈非尼
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
      ≥25.04 mg/mL
      insoluble in H2O
  9. 4-Chlorophenylguanidine hydrochloride
    A4445 4-Chlorophenylguanidine hydrochloride
    Target: Urokinases
    Summary: 尿激酶(urokinase)抑制剂
      Soluble to 100 mM in H2O
  10. AST 487
    A3194 AST 487
     1 Citation
    Target: RET
    Summary: RET激酶抑制剂
      ≥26.5 mg/mL
      insoluble in H2O

12件产品中的 1-10

页面
每页